Nova stock holds after TA-35 setback as Q2 2026 guidance lifts outlook
Published on 09/01/2026 at 15:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Nova Ltd. stock (ISIN IL0010845577) is trading within its 52-week band on September 1, 2026, after a recent pullback on the Tel Aviv TA-35 index that followed record quarterly results and a stronger revenue outlook for the rest of the year. Per recent market data, the shares reached a 52-week range between $154.54 and $289.42, with the upper end touched in the latest trading sessions, underscoring how strongly the stock has rerated on the back of its 2026 performance.
Record Q2 2026 results and guidance
Nova reported record Q2 2026 results and an upbeat outlook for the remainder of the year, marking the most recent fundamental snapshot available to investors. A detailed earnings review published on September 1, 2026, highlights that Q2 2026 revenue reached a new high compared with the prior-year quarter, with profitability metrics also progressing and supporting a more confident stance on the company’s growth path. In Q2 2026 the company’s results were strong enough to underpin new guidance for the second half of 2026, with management outlining a revenue range that signals continued sequential growth.
One same-day analysis of Nova’s Q2 2026 numbers notes that management expects revenue between $277 million and $287 million for the coming period, which represents sequential growth of 9 percent to 13 percent compared with the preceding quarter. This quantified guidance range provides a clear benchmark: even at the low end, the company targets mid-single digit to low-double digit percentage growth versus the prior quarter, while the high end implies a continuation of the momentum that pushed Q2 2026 to record levels. For investors, the fact that the guidance is expressed as a concrete range helps frame scenario analysis around potential revenue outcomes and margin leverage.
The Q2 2026 report also underpins the narrative that Nova’s business model is scaling well as the semiconductor equipment cycle recovers. With Q2 2026 revenue at a record level, and guidance suggesting further expansion into the $277 million to $287 million band, the company’s topline profile now spans a higher base than in earlier fiscal periods. Historically, Nova’s revenue had been materially lower in prior years, so the latest quarter marks a step-change that reflects both stronger demand conditions and deeper penetration with key customers in advanced process control solutions.
Stock reaction and TA-35 index context
The strong fundamentals have been met with mixed short-term market reaction. In a performance update dated August 31, 2026, the TA-35 index – which includes Nova – was reported up 1 percent over August, while Nova’s listing on the index fell 6.06 percent over the same period. This makes Nova one of the more volatile constituents of the index, suffering a mid-single digit percentage decline despite the benchmark’s modest gain. The move highlights how quickly sentiment can shift: even with a 1 percent rise in the TA-35, Nova’s shares moved in the opposite direction.
The 6.06 percent decline over the month stands out as a quantified comparison against the TA-35’s gain and against peer performance. In the same report, another semiconductor equipment peer fell 4.82 percent, underlining that Nova’s drawdown was steeper than at least one comparable name in the domestic market. For investors this difference in performance matters: on the one hand, Nova’s record Q2 2026 report and 9 percent to 13 percent sequential revenue guidance indicate operational strength; on the other, the 6.06 percent August share-price drop shows that the market has taken some profits or repriced risk despite the solid fundamentals.
Looking at recent pricing data for Nova’s Nasdaq-listed shares, the stock’s previous close was $245.43, with an intraday trading range in the latest session between $257.04 and $289.42 and a 52-week range between $154.54 and $289.42. As of the most recent quote snapshot on September 1, 2026, the observed bid of $267.81 and ask of $269.91 point to trading levels well above the prior close and closer to the top of the recent intraday range. The fact that the stock is now trading in the upper third of its 52-week band, with the high at $289.42, shows how far the shares have run from the $154.54 low that marked the start of the latest cycle.
In practice, this configuration means that even with the 6.06 percent August decline in the local TA-35 listing, Nova’s global equity story still reflects a strong rerating. A move from a 52-week low of $154.54 to recent levels in the high $260s to $280s range implies a large percentage gain over the past year. At today’s levels, the stock is trading relatively close to its 52-week high, suggesting that investors continue to price in sustained demand for the company’s process control tools, even as broader semiconductor and technology indices experience periods of consolidation.
Outlook and investor takeaways
For investors, the combination of record Q2 2026 earnings, quantitative guidance of $277 million to $287 million in revenue for the upcoming period, and a meaningful 6.06 percent August pullback offers a nuanced picture. On one side, the earnings trajectory and guidance range suggest that Nova has improved its revenue base and that management has sufficient visibility to target mid-single to low-double digit sequential growth. On the other, the recent market reaction indicates that the shares are not immune to profit-taking or cyclical concerns, especially given their strong position relative to the 52-week high.
One way to interpret the current setup is that Nova’s stock performance is now more sensitive to incremental data points than to broad narrative shifts. With Q2 2026 already marked as a record quarter, investors will look to subsequent prints to confirm whether revenue can consistently remain in or above the $277 million to $287 million range. If future quarters come in ahead of the top end of guidance, the re-rating could continue; if results fall short, the stock’s position close to its 52-week high may lead to sharper corrections. The quantified guidance range therefore acts as both a floor and a ceiling for expectations in the near term.
The TA-35 index context adds another dimension to this outlook. The 1 percent August rise in the index combined with Nova’s 6.06 percent decline suggests that the stock can decouple from the broader Israeli equity market, whether due to company-specific news flow, sector dynamics in global semiconductors, or valuation considerations. Investors who benchmark to the TA-35 need to account for this idiosyncratic volatility, especially given that other semiconductor peers in the index also posted declines, albeit less pronounced than Nova’s. As the global semiconductor cycle evolves, the interaction between Nova’s fundamentals and its index position will likely continue to influence short-term price moves.
Nova’s process control solutions in semiconductor manufacturing
At the heart of Nova’s business is its portfolio of process control systems used in semiconductor manufacturing across regions such as Taiwan, the United States, China, and Korea. The company designs, develops, produces, and sells metrology and inspection tools that help chipmakers monitor and adjust critical steps in advanced fabrication processes. These tools support nodes used in logic, memory, and foundry applications, where precise process control is essential to achieving yield, performance, and reliability targets.
Nova’s systems are deployed in-line and in-fab, allowing customers to capture data on film thickness, critical dimensions, and three-dimensional structures that are characteristic of modern semiconductor devices. This data feeds into closed-loop control algorithms that can adjust etch, deposition, and lithography parameters in near real time. In advanced process nodes where variability must be minimized at nanometer scales, the ability to detect and correct deviations quickly is a key differentiator. Nova’s tools are designed to integrate with customers’ existing manufacturing execution systems, creating a unified view of process health across multiple steps and tools.
The demand environment for these solutions has been underpinned by structural trends in the semiconductor industry, including the growth of artificial intelligence workloads, the expansion of data center infrastructure, and continued investment in leading-edge fabrication capacity. As chip designs become more complex and device architectures move to three-dimensional structures, the metrology challenges increase, driving higher value for sophisticated process control systems. Nova’s record Q2 2026 results can be viewed in this context: increased complexity and tighter process windows create more opportunities for the company’s tools to deliver measurable yield and cost benefits to customers.
Stock level and currency context
Nova’s primary equity listing trades on Nasdaq under the symbol NVMI in U.S. dollars, while the company also has a listing on the Tel Aviv Stock Exchange that is part of the TA-35 index. As of the latest available market data on September 1, 2026, the Nasdaq shares show a previous close of $245.43, an intraday range between $257.04 and $289.42, and a 52-week range between $154.54 and $289.42. This situates the current trading level relatively close to the upper end of both the intraday and 52-week ranges, indicating that the market continues to value the stock on the strength of its recent earnings and guidance.
For U.S.-based investors, the Nasdaq listing provides direct exposure to Nova’s semiconductor process control business in U.S. dollars, aligning with portfolio construction practices that emphasize liquidity and currency consistency. For Israeli and regional investors, the TASE listing offers a way to hold the stock within domestic index structures such as the TA-35, but the underlying business drivers remain the same: record Q2 2026 results, a quantified revenue guidance range of $277 million to $287 million, and the tension between strong fundamentals and a 6.06 percent August decline at the index constituent level.
Read more
Investors who want deeper detail on Nova’s index performance and recent market reaction can review the TA-35 performance update, which quantifies Nova’s 6.06 percent decline versus the index’s 1 percent gain and peer movements. A separate analysis of Q2 2026 results and guidance provides additional granularity on revenue trends, margin development, and management’s expectations for the remainder of 2026, including the $277 million to $287 million revenue range referenced above.
Process control systems for advanced fabs
Nova’s representative product line consists of advanced metrology and process control platforms that serve leading semiconductor fabrication plants worldwide. These systems are designed to support nodes that require precise control of line widths, film thickness, and three-dimensional geometries in complex device structures. By combining optical and x-ray based measurement techniques with sophisticated modeling, Nova’s tools can deliver accurate, high-throughput data that feeds into customers’ process optimization workflows.
In practical terms, a semiconductor manufacturer deploying Nova’s tools can monitor critical dimensions at each lithography and etch step, detect deviations from target patterns, and adjust recipes before yield is compromised. This is particularly valuable in leading-edge logic and memory production, where a small variation in one step can propagate into performance issues across millions of devices. Nova’s solutions are often integrated into fully automated fab environments that rely on real-time data to balance throughput, yield, and quality, making the company’s products an integral part of modern process infrastructure.
Nova stock level and investor lens
Based on the latest Nasdaq quote snapshot on September 1, 2026, Nova’s stock trades within a 52-week range of $154.54 to $289.42 and has recently moved between $257.04 and $289.42 intraday, with a previous close at $245.43. These figures show that the shares are currently valued close to their recent highs, even as the TA-35 index listing recorded a 6.06 percent decline in August against a 1 percent rise in the index. For investors, this juxtaposition highlights both the upside captured in the past year and the short-term volatility that can emerge as markets digest record Q2 2026 results and a revenue guidance range of $277 million to $287 million.
Fact box
Company: Nova Ltd.
ISIN: IL0010845577
Ticker: NVMI
Exchange: Nasdaq / Tel Aviv Stock Exchange (TA-35 index constituent)
Price (as of September 1, 2026, latest quote snapshot): previous close $245.43, intraday range $257.04-$289.42 USD
Market cap: not specified in available data
Sector / Industry: Semiconductors - process control and metrology equipment
Index membership: TA-35 (Israel)
